Vivani Net Income From Continuing Ops vs Reconciled Depreciation Analysis

VANI Stock

USD 1.05 0.02 1.94%

Vivani Medical financial indicator trend analysis is much more than just breaking down Vivani Medical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vivani Medical is a good investment. Please check the relationship between Vivani Medical Net Income From Continuing Ops and its Reconciled Depreciation accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vivani Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more detail on how to invest in Vivani Stock please use our How to Invest in Vivani Medical guide.

Net Income From Continuing Ops vs Reconciled Depreciation

Net Income From Continuing Ops vs Reconciled Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Vivani Medical Net Income From Continuing Ops account and Reconciled Depreciation. At this time, the significance of the direction appears to have pay attention.

The correlation between Vivani Medical's Net Income From Continuing Ops and Reconciled Depreciation is -0.81. Overlapping area represents the amount of variation of Net Income From Continuing Ops that can explain the historical movement of Reconciled Depreciation in the same time period over historical financial statements of Vivani Medical, assuming nothing else is changed. The correlation between historical values of Vivani Medical's Net Income From Continuing Ops and Reconciled Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income From Continuing Ops of Vivani Medical are associated (or correlated) with its Reconciled Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Reconciled Depreciation has no effect on the direction of Net Income From Continuing Ops i.e., Vivani Medical's Net Income From Continuing Ops and Reconciled Depreciation go up and down completely randomly.

Correlation Coefficient

-0.81

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Net Income From Continuing Ops

Reconciled Depreciation

Most indicators from Vivani Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vivani Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vivani Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more detail on how to invest in Vivani Stock please use our How to Invest in Vivani Medical guide.The Vivani Medical's current Issuance Of Capital Stock is estimated to increase to about 19.8 M, while Selling General Administrative is projected to decrease to under 8 M.

	2022	2023	2024	2025 (projected)
Total Operating Expenses	21.2M	27.0M	24.7M	24.8M
Cost Of Revenue	381K	357K	321.3K	305.2K

Total Operating Expenses Cost Of Revenue

Vivani Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Other Liab
Total Assets		0.25	0.47	0.64	0.9	0.51	0.41	-0.52	0.07	0.19	0.76	0.53	0.5	0.92	-0.03	0.65	0.46	0.26	0.13	0.86	0.49	0.39	0.9	0.56	-0.19	-0.22
Short Long Term Debt Total	0.25		-0.25	-0.23	-0.18	0.65	-0.18	0.54	0.29	-0.28	0.0	0.65	0.69	-0.02	-0.31	0.55	-0.18	1.0	-0.32	0.26	0.59	0.91	-0.07	0.18	-0.63	-0.33
Other Current Liab	0.47	-0.25		0.95	0.54	-0.04	0.44	-0.4	-0.73	0.47	0.24	-0.04	-0.13	0.45	0.59	-0.1	0.6	-0.24	0.68	0.36	0.2	-0.06	0.58	-0.24	0.65	0.05
Total Current Liabilities	0.64	-0.23	0.95		0.71	0.16	0.4	-0.57	-0.65	0.57	0.47	0.16	0.08	0.61	0.42	0.16	0.56	-0.22	0.51	0.57	0.37	0.03	0.7	0.04	0.5	-0.14
Total Stockholder Equity	0.9	-0.18	0.54	0.71		0.25	0.49	-0.76	0.01	0.28	0.77	0.28	0.24	0.94	0.08	0.44	0.55	-0.17	0.25	0.76	0.24	0.0	0.94	0.54	0.02	-0.11
Property Plant And Equipment Net	0.51	0.65	-0.04	0.16	0.25		-0.08	0.09	0.16	-0.04	0.34	1.0	0.98	0.21	-0.32	0.91	0.01	0.62	-0.38	0.57	0.94	0.8	0.16	0.58	-0.64	-0.73
Current Deferred Revenue	0.41	-0.18	0.44	0.4	0.49	-0.08		0.01	-0.01	-0.2	-0.15	-0.08	-0.08	0.51	0.07	-0.09	0.91	-0.18	0.42	0.04	-0.05	-0.09	0.54	-0.09	0.12	0.03
Net Debt	-0.52	0.54	-0.4	-0.57	-0.76	0.09	0.01		0.16	-0.55	-0.84	0.06	0.12	-0.65	-0.17	-0.17	-0.07	0.51	-0.14	-0.57	0.07	0.39	-0.64	-0.45	-0.32	-0.1
Retained Earnings	0.07	0.29	-0.73	-0.65	0.01	0.16	-0.01	0.16		-0.62	0.04	0.17	0.28	0.08	-0.44	0.31	-0.12	0.28	-0.32	0.04	-0.14	0.14	-0.01	0.48	-0.83	-0.08
Accounts Payable	0.19	-0.28	0.47	0.57	0.28	-0.04	-0.2	-0.55	-0.62		0.45	-0.02	-0.07	0.25	-0.01	0.07	-0.14	-0.25	0.03	0.35	0.14	-0.1	0.27	-0.09	0.53	-0.08
Cash	0.76	0.0	0.24	0.47	0.77	0.34	-0.15	-0.84	0.04	0.45		0.37	0.33	0.75	-0.06	0.59	-0.06	0.03	-0.11	0.83	0.3	0.14	0.7	0.7	-0.08	-0.14
Non Current Assets Total	0.53	0.65	-0.04	0.16	0.28	1.0	-0.08	0.06	0.17	-0.02	0.37		0.99	0.24	-0.33	0.93	0.01	0.62	-0.39	0.59	0.94	0.8	0.19	0.61	-0.65	-0.73
Non Currrent Assets Other	0.5	0.69	-0.13	0.08	0.24	0.98	-0.08	0.12	0.28	-0.07	0.33	0.99		0.23	-0.37	0.94	0.0	0.66	-0.41	0.56	0.91	0.83	0.17	0.6	-0.73	-0.77
Cash And Short Term Investments	0.92	-0.02	0.45	0.61	0.94	0.21	0.51	-0.65	0.08	0.25	0.75	0.24	0.23		-0.03	0.45	0.52	0.01	0.16	0.71	0.19	0.15	0.98	0.49	-0.02	-0.1
Net Receivables	-0.03	-0.31	0.59	0.42	0.08	-0.32	0.07	-0.17	-0.44	-0.01	-0.06	-0.33	-0.37	-0.03		-0.4	0.22	-0.3	0.64	-0.07	-0.15	-0.27	0.12	-0.4	0.5	0.23
Common Stock Shares Outstanding	0.65	0.55	-0.1	0.16	0.44	0.91	-0.09	-0.17	0.31	0.07	0.59	0.93	0.94	0.45	-0.4		-0.03	0.54	-0.47	0.71	0.82	0.72	0.37	0.77	-0.68	-0.71
Short Term Investments	0.46	-0.18	0.6	0.56	0.55	0.01	0.91	-0.07	-0.12	-0.14	-0.06	0.01	0.0	0.52	0.22	-0.03		-0.18	0.61	0.1	0.1	-0.01	0.61	-0.08	0.15	-0.15
Non Current Liabilities Total	0.26	1.0	-0.24	-0.22	-0.17	0.62	-0.18	0.51	0.28	-0.25	0.03	0.62	0.66	0.01	-0.3	0.54	-0.18		-0.31	0.27	0.56	0.91	-0.03	0.16	-0.61	-0.32
Inventory	0.13	-0.32	0.68	0.51	0.25	-0.38	0.42	-0.14	-0.32	0.03	-0.11	-0.39	-0.41	0.16	0.64	-0.47	0.61	-0.31		-0.04	-0.24	-0.28	0.34	-0.47	0.47	0.27
Other Current Assets	0.86	0.26	0.36	0.57	0.76	0.57	0.04	-0.57	0.04	0.35	0.83	0.59	0.56	0.71	-0.07	0.71	0.1	0.27	-0.04		0.54	0.37	0.69	0.68	-0.22	-0.21
Other Stockholder Equity	0.49	0.59	0.2	0.37	0.24	0.94	-0.05	0.07	-0.14	0.14	0.3	0.94	0.91	0.19	-0.15	0.82	0.1	0.56	-0.24	0.54		0.79	0.18	0.41	-0.41	-0.77
Total Liab	0.39	0.91	-0.06	0.03	0.0	0.8	-0.09	0.39	0.14	-0.1	0.14	0.8	0.83	0.15	-0.27	0.72	-0.01	0.91	-0.28	0.37	0.79		0.12	0.24	-0.58	-0.62
Total Current Assets	0.9	-0.07	0.58	0.7	0.94	0.16	0.54	-0.64	-0.01	0.27	0.7	0.19	0.17	0.98	0.12	0.37	0.61	-0.03	0.34	0.69	0.18	0.12		0.37	0.07	-0.09
Short Term Debt	0.56	0.18	-0.24	0.04	0.54	0.58	-0.09	-0.45	0.48	-0.09	0.7	0.61	0.6	0.49	-0.4	0.77	-0.08	0.16	-0.47	0.68	0.41	0.24	0.37		-0.58	-0.35
Common Stock	-0.19	-0.63	0.65	0.5	0.02	-0.64	0.12	-0.32	-0.83	0.53	-0.08	-0.65	-0.73	-0.02	0.5	-0.68	0.15	-0.61	0.47	-0.22	-0.41	-0.58	0.07	-0.58		0.49
Other Liab	-0.22	-0.33	0.05	-0.14	-0.11	-0.73	0.03	-0.1	-0.08	-0.08	-0.14	-0.73	-0.77	-0.1	0.23	-0.71	-0.15	-0.32	0.27	-0.21	-0.77	-0.62	-0.09	-0.35	0.49

Click cells to compare fundamentals

Vivani Medical Account Relationship Matchups

Vivani Medical fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	5.2M	5.5M	51.1M	45.8M	41.6M	25.4M
Short Long Term Debt Total	2.5M	1.8M	955K	20.7M	19.3M	10.4M
Other Current Liab	573K	895K	3.7M	3.8M	3.8M	3.3M
Total Current Liabilities	2.2M	2.1M	6.8M	5.7M	6.0M	6.1M
Total Stockholder Equity	2.0M	2.5M	44.3M	20.8M	17.6M	13.5M
Property Plant And Equipment Net	2.6M	2.8M	2.0M	21.3M	19.7M	20.6M
Net Debt	386K	(366K)	(44.1M)	42K	961K	1.0M
Retained Earnings	(46.1M)	(58.9M)	(72.8M)	(98.4M)	(121.9M)	(128.0M)
Accounts Payable	223K	281K	1.2M	542K	817K	813.6K
Cash	2.1M	2.2M	45.1M	20.7M	18.4M	11.8M
Non Current Assets Total	2.8M	3.0M	3.6M	22.7M	21.1M	22.2M
Cash And Short Term Investments	2.1M	2.2M	45.1M	20.7M	18.4M	15.8M
Common Stock Shares Outstanding	6.9M	11.0M	38.2M	50.9M	55.0M	57.7M
Liabilities And Stockholders Equity	5.2M	5.5M	51.1M	45.8M	41.6M	25.4M
Non Current Liabilities Total	1.1M	902K	2.1M	19.3M	18.0M	9.8M
Other Current Assets	348K	291K	2.5M	2.4M	1.8M	1.1M
Other Stockholder Equity	5.0M	6.7M	8.0M	119.1M	139.5M	146.5M
Total Liab	3.3M	3.0M	6.8M	25.0M	24.0M	25.1M
Total Current Assets	2.4M	2.5M	47.5M	23.1M	20.4M	19.9M
Accumulated Other Comprehensive Income	(448K)	(379K)	35K	140K	161K	169.1K
Short Term Debt	1.4M	910K	1.9M	1.4M	1.3M	1.1M
Common Stock	43.0M	54.6M	109.1M	5K	6K	5.7K

Currently Active Assets on Macroaxis

AMT	American Tower Corp
HLTOY	Hellenic Telecommunications Org
NFLX	Netflix
EPGFX	Europac Gold Fund
FTGFF	Firan Technology Group

When determining whether Vivani Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vivani Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vivani Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vivani Medical Stock:

How To Invest In Vivani

Details

Is Vivani Stock a good investment?

Details

What is Vivani Medical's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vivani Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more detail on how to invest in Vivani Stock please use our How to Invest in Vivani Medical guide.

You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vivani Medical. If investors know Vivani will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vivani Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.43)

Return On Assets

(0.35)

Return On Equity

(1.22)

The market value of Vivani Medical is measured differently than its book value, which is the value of Vivani that is recorded on the company's balance sheet. Investors also form their own opinion of Vivani Medical's value that differs from its market value or its book value, called intrinsic value, which is Vivani Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vivani Medical's market value can be influenced by many factors that don't directly affect Vivani Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Vivani Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivani Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vivani Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Vivani Net Income From Continuing Ops vs Reconciled Depreciation Analysis

Net Income From Continuing Ops vs Reconciled Depreciation

Net Income From Continuing Ops vs Reconciled Depreciation Correlation Analysis

Correlation Coefficient

Net Income From Continuing Ops

Reconciled Depreciation

Vivani Medical fundamental ratios Correlations

Vivani Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Vivani Medical fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Non Currrent Assets Other	+ 0.99	Non Current Assets Total
Non Currrent Assets Other	+ 0.98	Property Plant And Equipment Net
Total Current Assets	+ 0.98	Cash And Short Term Investments
Total Current Liabilities	+ 0.95	Other Current Liab

Cash	- 0.84	Net Debt
Common Stock	- 0.83	Retained Earnings
Other Liab	- 0.77	Other Stockholder Equity
Other Liab	- 0.77	Non Currrent Assets Other
Net Debt	- 0.76	Total Stockholder Equity
Common Stock	- 0.73	Non Currrent Assets Other